Funding News
Butterfly Learnings Raises Rs 65 Crore — India's First Full-Stack Paediatric Neurodevelopmental Platform Is Now Scaling Its Autism Screening to Every Paediatrician in India
By Mustafa Shariff, Editor in Chief · August 22,2026 · 2 mins read
Summary
- Butterfly Learnings Raises Rs 65 Crore Pre-Series B: India's First Full-Stack Paediatric Neurodevelopmental Platform Scales Autism Screening
- Butterfly Learnings raised Rs 65 crore in Pre-Series B led by Inflexor Ventures to expand its 90+ centre network, scale Get SET Early autism screening (CDSCO-approved from age 1), and strengthen AI capabilities for India's 45M children with neurodevelopmental conditions.
"Nearly 45 million children in India live with autism, ADHD or learning disabilities. The gap is not awareness — it is access to timely, evidence-based care. Butterfly Learnings exists to close that gap. Our Get SET Early screening solution, now CDSCO-approved to screen children from one year of age, makes early identification possible at the paediatrician's office — the first point of contact for most families. This funding allows us to take that screening tool to hospitals and paediatricians at scale, so that no child's window for early intervention closes simply because the right tools were not available."
Butterfly Learnings, India's first full-stack paediatric behavioural health platform for neurodivergent children, raised Rs 65 crore in a Pre-Series B round on August 19, 2026, led by Inflexor Ventures. Existing investors Insitor Impact Asia Fund, Enzia Ventures, and IIMA Ventures continued their support, reflecting strong investor conviction in the company's trajectory.
Founded in 2021 by Dr Sonam Kothari — a practising paediatric neurologist — and Dr Abhishek Sen, Butterfly Learnings built its model around a clinical insight: India's 45 million children with autism, ADHD, and learning disabilities are almost all diagnosed too late, because the screening and intervention infrastructure does not exist close enough to where families first seek help. The company now operates 90-plus centres across 22-plus Indian cities, delivering clinical therapy, inclusive schooling, diagnostics, digital therapeutics, and technology-enabled interventions under one platform.
Get SET Early: The Screening Breakthrough
Butterfly Learnings' CDSCO-approved Get SET Early autism screening solution is the company's most commercially scalable asset. Designed to be deployed by paediatricians and in hospital settings, it can screen children from as early as one year of age — years before most Indian children with autism are currently diagnosed. The funding will specifically drive hospital and paediatrician partnerships to deploy Get SET Early at scale — transforming the first clinical contact point (the paediatric clinic) into an autism early warning system.
What the Funding Covers
Proceeds will fund: centre network expansion beyond Maharashtra across key Indian cities, AI capability development on Butterfly's proprietary clinical data, deployment of Get SET Early through hospital and paediatrician partnerships, and scale-up of its therapist training institute (accredited by the Behavioural Health Center of Excellence).
BHC Perspective
For BHC's healthcare ecosystem, Butterfly Learnings is a clinical-depth startup — not a consumer app, but a specialist care delivery network built by clinicians. The CDSCO-approved screening tool and the hospital-paediatrician partnership model define what fundable, scalable, clinically grounded paediatric healthtech looks like in 2026.
Frequently Asked Questions
Q: What is Butterfly Learnings?
A: India's first full-stack paediatric behavioural health platform for neurodivergent children — 90+ centres, 22+ cities. Founded 2021 by Dr Sonam Kothari (paediatric neurologist) and Dr Abhishek Sen. Clinical therapy, inclusive schooling, diagnostics, digital therapeutics, and AI tools for autism, ADHD, and learning disabilities.
Q: What is Get SET Early?
A: A CDSCO-approved autism screening solution deployable from 1 year of age, designed for paediatricians and hospital settings. The key scaling tool in Butterfly Learnings' Pre-Series B deployment plan — enabling early identification at the paediatric clinic level.
Q: What round and who invested?
A: Pre-Series B round of Rs 65 crore ($6.7M), led by Inflexor Ventures. Existing investors Insitor Impact Asia Fund, Enzia Ventures, and IIMA Ventures also participated.